Failure of magnesium to protect isolated cardiomyocytes from effects of hypoxia or metabolic poisoning

Clinical Cardiology

Volumn 23, Issue 7, 2000, Pages 530-534

  Gallagher, Mark M ^a,b   Allshire, Ashley P ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Contracture; Cytoprotection; Ischemic myocardium; Magnesium; Myocardial infarction

Indexed keywords

DEOXYGLUCOSE; MAGNESIUM ION; SODIUM CYANIDE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOXIA; NONHUMAN; RAT; REOXYGENATION;

EID: 0033946539     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230712     Document Type: Article

References (23)

1. Crawford T, Crawford MD: Prevalence and pathological changes of ischaemic heart disease in a hard-water and in a soft-water area. Lancet 1967;i:229-232
2. Elwood PC, Fehily AM, Ising H, Poor DJ, Pickering J, Kamel F: Dietary magnesium does not predict ischaemic heart disease in the Caerphilly cohort. Eur J Clin Nutr 1996;50:694-697
3. Abraham AS, Eylath U, Weinstein M, Czaczkes E: Serum magnesium levels in patients with acute myocardial infarction. N Engl J Med 1977;296:862-863
4. Kafka H, Langevin L, Armstrong PW: Serum magnesium and potassium in acute myocardial infarction. Arch Intern Med 1987; 147:465-469
5. Malkiel-Shapiro B, Bersohn 1: Parenteral magnesium sulphate therapy in coronary heart disease: A preliminary report on its clinical and laboratory aspects. Med Proc 1956;2:455-462
6. Horner SM: Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality: Meta-analysis of magnesium in acute myocardial infarction. Circulation 1992; 86:774-779
7. Leor J, Kloner RA: An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol 1995;75:1292-1293
8. Herzog WR, Schlossberg ML, MacMurdy KS, Edenbaum LR, Gerber MJ, Vogel RA, Serebruany VL: Timing of magnesium therapy affects experimental infarct size. Circulation 1995;92: 2622-2626
9. Christensen CW, Rieder MA, Silverstein EL, Gencheff NE: Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 1995;92:2617-2621
10. Barros LF, Chagas AC, da Luz PL, Pileggi F: Magnesium treatment of acute myocardial infarction: Effects on necrosis in an occlusion/reperfusion dog model. Int J Cardiol 1995;48:3-9
11. Kingma JG, Qiu Y, Hearse DJ: Influence of low-flow infusion and magnesium on tissue necrosis during regional ischaemia in the canine myocardium. Can J Physiol Pharmacol 1992;70:1004-1010
12. Woods KL, Fletcher S, Roffe C, Haider Y: Intravenous magnesium sulphate in suspected myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT 2). Lancet 1992;339;1553-1558
13. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group: ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685
14. Allshire AP, Cobbold PH: Causes and effects of changes in cytosolic free calcium in the hypoxic myocardial cell. In Pathophysiology of Severe Ischaemic Myocardial Injury (Ed. Piper HM), p. 297-314. Dordrecht: Kluwer (1990)
15. Owens LM, Fralix TA, Murphy EM, Cascio WE, Gertes LS, Experimental Working Group: Correlation of ischaemia-induced extracellular and intracellular ion changes to cell-to-cell electrical uncoupling in isolated blood-perfused rabbit hearts. Circulation 1996;94:10-13
16. Woods KL: Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 1991;32:3-10
17. 2+ in single rat heart cells during anoxia and reoxygenation. Biochem J 1987;244:381-385
18. Antman EM: Magnesium in acute MI: Timing is critical (editorial). Circulation 1995;92:2367-2372
19. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CR, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E: Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;72:142-154
20. Rentrop KP, Feit F, Sherman W, Thornton JC: Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction: Report from the second Mount Sinai-New York University reperfusion trial. Circulation 1989;80: 1166-1175
21. LeLoir J, Grégoire G, Benhaddad A, Lapierre J, Derderian F: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-542
22. Amos B: Chance remarks (letter). Nature 1996;379:484
23. Dunthom D: Try, try, and try again (letter). Nature 1996;380:477